| Literature DB >> 19863383 |
Gordon Ramage1, Eilidh Mowat, Brian Jones, Craig Williams, Jose Lopez-Ribot.
Abstract
Fungal biofilms are an escalating clinical problem associated with significant rates of mortality. Candida albicans is the most notorious of all fungal biofilm formers. However, non-Candida species, yeasts such as Cryptococcus neoformans, and filamentous moulds such as Aspergillus fumigatus, have been shown to be implicated in biofilm-associated infections. Fungal biofilms have distinct developmental phases, including adhesion, colonisation, maturation and dispersal, which are governed by complex molecular events. Recalcitrance to antifungal therapy remains the greatest threat to patients with fungal biofilms. This review discusses our current understanding of the basic biology and clinical implications associated with fungal biofilms.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19863383 DOI: 10.3109/10408410903241436
Source DB: PubMed Journal: Crit Rev Microbiol ISSN: 1040-841X Impact factor: 7.624